Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic.
Cabero-Martínez A, Sánchez-Guijo F, López-Corral L, Pérez E, Avendaño A, Baile M, Cabrero M, Martín AA, Rodríguez A, Pérez B, Peña-Muñoz F, Román LG, Palomino D, López-Vázquez L, Vidriales MB, González-Diaz M, Mateos MV, Caballero MD. Cabero-Martínez A, et al. Among authors: caballero md. Front Med (Lausanne). 2020 Aug 26;7:462. doi: 10.3389/fmed.2020.00462. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32984363 Free PMC article.
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.
Labrador J, Lopez-Anglada L, Perez-Lopez E, Lozano FS, Lopez-Corral L, Sanchez-Guijo FM, Vazquez L, Perez Rivera JA, Martin-Herrero F, Sanchez-Barba M, Guerrero C, del Cañizo MC, Caballero MD, San Miguel JF, Alberca I, Gonzalez-Porras JR. Labrador J, et al. Among authors: caballero md. Haematologica. 2013 Mar;98(3):437-43. doi: 10.3324/haematol.2012.069559. Epub 2012 Aug 16. Haematologica. 2013. PMID: 22899581 Free PMC article.
Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
Labrador J, González-Rivero J, Monroy R, Lozano FS, López-Corral L, Caballero MD, Bastida JM, González-Porras JR. Labrador J, et al. Among authors: caballero md. Thromb Res. 2016 Jun;142:52-6. doi: 10.1016/j.thromres.2016.02.016. Epub 2016 Feb 18. Thromb Res. 2016. PMID: 26922092
Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell Lymphoma.
Alonso-Álvarez S, Alcoceba M, García-Álvarez M, Blanco O, Rodríguez M, Baile M, Caballero JC, Dávila J, Vidriales MB, Esteban C, Arias P, Díaz LG, Tamayo P, Caballero MD, Gutiérrez NC, González M, Martín A. Alonso-Álvarez S, et al. Among authors: caballero md. Cancers (Basel). 2020 Feb 18;12(2):474. doi: 10.3390/cancers12020474. Cancers (Basel). 2020. PMID: 32085520 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36164212
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.
Sanchez-Guijo FM, Sanchez-Abarca LI, Bueno C, Villaron E, Lopez-Holgado N, Vazquez L, Lopez-Fidalgo J, Perez-Simon JA, Caballero MD, del Cañizo MC, Orfao A, San Miguel JF. Sanchez-Guijo FM, et al. Among authors: caballero md. Biol Blood Marrow Transplant. 2005 May;11(5):354-61. doi: 10.1016/j.bbmt.2005.01.008. Biol Blood Marrow Transplant. 2005. PMID: 15846289 Free article. Clinical Trial.
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability.
Sanchez-Guijo FM, Sanchez-Abarca LI, Villaron E, Lopez-Holgado N, Alberca M, Vazquez L, Perez-Simon JA, Lopez-Fidalgo J, Orfao A, Caballero MD, Del Cañizo MC, San Miguel JF. Sanchez-Guijo FM, et al. Among authors: caballero md. Exp Hematol. 2005 Aug;33(8):935-43. doi: 10.1016/j.exphem.2005.04.009. Exp Hematol. 2005. PMID: 16038787 Free article.
Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N, Caballero MD, Alcoceba M, Sebastián E, Balanzategui A, Sarasquete ME, García-Sanz R, González-Díaz M. Puig N, et al. Among authors: caballero md. Ann Hematol. 2011 Feb;90(2):227-9. doi: 10.1007/s00277-010-0987-0. Epub 2010 May 27. Ann Hematol. 2011. PMID: 20506021 Free article. No abstract available.
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial.
Peñalver FJ, Márquez JA, Durán S, Giraldo P, Martín A, Montalbán C, Sancho JM, Ramírez MJ, Terol MJ, Capote FJ, Gutiérrez A, Sánchez B, López A, Salar A, Rodríguez-Caravaca G, Canales M, Caballero MD; GELTAMO (The Spanish Lymphoma Cooperative Group). Peñalver FJ, et al. Among authors: caballero md. Cancer Med. 2019 Nov;8(16):6955-6966. doi: 10.1002/cam4.2555. Epub 2019 Oct 1. Cancer Med. 2019. PMID: 31573746 Free PMC article. Clinical Trial.
154 results